» Articles » PMID: 35544908

SARS-CoV-2 Infection in Children and Adolescents: a Brazilian Experience

Overview
Specialty Pediatrics
Date 2022 May 11
PMID 35544908
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To describe clinical and epidemiological aspects of children and adolescents infected with the SARS-CoV-2 in the Municipality of Taubaté, SP, from March to November 2020.

Methods: Cross-sectional study with secondary data obtained from the Epidemiological Surveillance System about confirmed cases in city residents and from medical records of patients who were treated in hospitals in Taubaté, aged between 0 and 19 years. Chi-square and Student's t tests were used for comparisons.

Results: 677 cases in the studied age range were reported during the study period, corresponding to 10.1% of cases reported in the municipality. The rapid antibody test was the most used to confirm infection, followed by RT-PCR and serology. Symptoms were described in 57.7% of the cases, mainly fever and cough. Diarrhea was associated with age below 4 years, while fever, cough, headache, odynophagia, ageusia, anosmia, myalgia, and dyspnea were associated with an age ranging from 10 to 19 years. In the study period, there were no deaths from COVID-19 of residents of the municipality in the age group from 0 to 19 years.

Conclusions: The study was able to identify the proportion of involvement of COVID-19 in children and adolescents in the city, and the disease had a mild evolution. The main symptoms were fever and cough, but mainly diarrhea in younger children, and headache, odynophagia, anosmia, ageusia, and myalgia in adolescents.

Citing Articles

Association Between Single-Nucleotide Polymorphisms in (), , and Genes with Severe Symptoms in Children Presenting COVID-19.

Andrade A, Bentes A, Diniz L, Carvalho S, Kroon E, Campos M Viruses. 2025; 17(1).

PMID: 39861824 PMC: 11769468. DOI: 10.3390/v17010035.


Polymorphisms in the ACE I/D (4646994) and ACE2 G8790A (2285666) in Young Children Living in the Amazon Region and SARS-CoV-2 Infection.

Pimenta Y, Bonfim F, Figueiredo C, Pedroso B, Silva M, Olivares A Trop Med Infect Dis. 2024; 9(11).

PMID: 39591276 PMC: 11598624. DOI: 10.3390/tropicalmed9110270.


Clinical and Epidemiological Assessment of Children and Adolescents Hospitalized with SARS-CoV-2 in the Pre-Amazon Region.

Ribeiro M, Sousa L, Oliveira J, Pinto D, Batista L, Lobato L Biomedicines. 2024; 12(3).

PMID: 38540117 PMC: 10968157. DOI: 10.3390/biomedicines12030504.


Morbidity trend and space-time clusters of COVID-19 occurrence in children and adolescents.

da Rocha C, Machado L, Silva P, Freitas B, Endruweit Battisti I, Dos Santos E J Pediatr (Rio J). 2023; 100(2):196-203.

PMID: 37952930 PMC: 10943318. DOI: 10.1016/j.jped.2023.10.004.

References
1.
Williams P, Howard-Jones A, Hsu P, Palasanthiran P, Gray P, McMullan B . SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings. Pathology. 2020; 52(7):801-808. PMC: 7437539. DOI: 10.1016/j.pathol.2020.08.001. View

2.
Nascimento L, Batista G, Dias N, Catelani C, Becker D, Rodrigues L . [Spatial analysis of neonatal mortality in Paraíba Valley, Southeastern Brazil, 1999 to 2001]. Rev Saude Publica. 2007; 41(1):94-100. DOI: 10.1590/s0034-89102007000100013. View

3.
Christy A . COVID-19: A Review for the Pediatric Neurologist. J Child Neurol. 2020; 35(13):934-939. DOI: 10.1177/0883073820939387. View

4.
Ludvigsson J . Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020; 109(6):1088-1095. PMC: 7228328. DOI: 10.1111/apa.15270. View

5.
Sena G, Lima T, Vidal S, Duarte M, Bezerra P, Fonseca Lima E . Clinical Characteristics and Mortality Profile of COVID-19 Patients Aged less than 20 years Old in Pernambuco - Brazil. Am J Trop Med Hyg. 2021; 104(4):1507-1512. PMC: 8045659. DOI: 10.4269/ajtmh.20-1368. View